Judge denies Abbott request for retrial, lower damages in $500M baby formula case


Similac Baby Formula

LPETTET/iStock Unreleased via Getty Images

A judge denied a request by Abbott Laboratories (NYSE:ABT) for a new trial after a St. Louis jury awarded a plaintiff $500 million in an infant formula case in July.

Michael Noble of St. Louis City Circuit Court denied the Abbott (


Leave a Comment